RivR is a negative regulator of virulence factor expression in group a Streptococcus

Infection and Immunity

Volumn 81, Issue 1, 2013, Pages 364-372

  Treviño, Jeanette ^a   Liu, Zhuyun ^a   Cao, Tram N ^a   Ramirez Peña, Esmeralda ^a   Sumby, Paul ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN BINDING PROTEIN; BACTERIAL PROTEIN; BINDING PROTEIN; GRAB PROTEIN; HASABC PROTEIN; HYALURONIC ACID; HYALURONIDASE; MESSENGER RNA; REGULATOR PROTEIN; ROFA LIKE PROTEIN IV; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ANGULAR LEAF SPOT; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM MUTANT; CELL ADHESION; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE REGULATORY NETWORK; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REGULATOR GENE; REGULON; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A;

ANIMALS; BACTERIAL CAPSULES; BACTERIAL PROTEINS; CARRIER PROTEINS; CELL LINE; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; KERATINOCYTES; MICE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRULENCE; VIRULENCE FACTORS;

EID: 84871886762     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00703-12     Document Type: Article

References (40)

1. Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
2. Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. 1991. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. U. S. A. 88:8317-8321.
3. Schrager HM, Alberti S, Cywes C, Dougherty GJ, Wessels MR. 1998. Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J. Clin. Invest. 101:1708-1716.
4. McArthur JD, Cook SM, Venturini C, Walker MJ. 2012. The role of streptokinase as a virulence determinant of Streptococcus pyogenes - potential for therapeutic targeting. Curr. Drug Targets 13:297-307.
5. Rasmussen M, Muller HP, Bjorck L. 1999. Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin. J. Biol. Chem. 274:15336 -15344.
6. Kreikemeyer B, McIver KS, Podbielski A. 2003. Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends Microbiol. 11:224-232.
7. Barnett TC, Bugrysheva JV, Scott JR. 2007. Role of mRNA stability in growth phase regulation of gene expression in the group A Streptococcus. J. Bacteriol. 189:1866-1873.
8. Kreikemeyer B, Beckert S, Braun-Kiewnick A, Podbielski A. 2002. Group A streptococcal RofA-type global regulators exhibit a strainspecific genomic presence and regulation pattern. Microbiology 148:1501-1511.
9. Lizano S, Luo F, Tengra FK, Bessen DE. 2008. Impact of orthologous gene replacement on the circuitry governing pilus gene transcription in streptococci. PLoS One 3:e3450.
10. Liu Z, Treviño J, Ramirez-Peña E, Sumby P. 2012. The small regulatory RNAFasX controls pilus expression and adherence in the human bacterial pathogen group A Streptococcus. Mol. Microbiol. 86:140-154.
11. Levin JC, Wessels MR. 1998. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol. Microbiol. 30:209-219.
12. McIver KS, Heath AS, Green BD, Scott JR. 1995. Specific binding of the activator Mga to promoter sequences of the emm and scpA genes in the group A Streptococcus. J. Bacteriol. 177:6619-6624.
13. Ribardo DA, McIver KS. 2006. Defining the Mga regulon: comparative transcriptome analysis reveals both direct and indirect regulation by Mga in the group A streptococcus. Mol. Microbiol. 62:491-508.
14. Hondorp ER, McIver KS. 2007. The Mga virulence regulon: infection where the grass is greener. Mol. Microbiol. 66:1056-1065.
15. 2+. Proc. Natl. Acad. Sci. U. S. A. 100:4227-4232.
16. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM. 2006. Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2:e5.
17. Graham MR, Smoot LM, Migliaccio CA, Virtaneva K, Sturdevant DE, Porcella SF, Federle MJ, Adams GJ, Scott JR, Musser JM. 2002. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc. Natl. Acad. Sci. U. S. A. 99:13855-13860.
18. Federle MJ, McIver KS, Scott JR. 1999. A response regulator that represses transcription of several virulence operons in the group A Streptococcus. J. Bacteriol. 181:3649-3657.
19. Treviño J, Perez N, Ramirez-Peña E, Liu Z, Shelburne SA, III, Musser JM, Sumby P. 2009. CovS simultaneously activates and inhibits the CovRmediated repression of distinct subsets of group A Streptococcus virulence factor-encoding genes. Infect. Immun. 77:3141-3149.
20. Roberts SA, Churchward GG, Scott JR. 2007. Unraveling the regulatory network in Streptococcus pyogenes: the global response regulator CovR represses rivR directly. J. Bacteriol. 189:1459 -1463.
21. Leday TV, Gold KM, Kinkel TL, Roberts SA, Scott JR, McIver KS. 2008. TrxR, a new CovR-repressed response regulator that activates the Mga virulence regulon in group A Streptococcus. Infect. Immun. 76:4659-4668.
22. Roberts SA, Scott JR. 2007. RivR and the small RNA RivX: the missing links between the CovR regulatory cascade and the Mga regulon. Mol. Microbiol. 66:1506-1522.
23. Ramirez-Peña E, Treviño J, Liu Z, Perez N, Sumby P. 2010. The group A Streptococcus small regulatory RNA FasX enhances streptokinase activityby increasing the stability of the ska mRNA transcript. Mol. Microbiol.78:1332-1347.
24. Sumby P, Barbian KD, Gardner DJ, Whitney AR, Welty DM, Long RD, Bailey JR, Parnell MJ, Hoe NP, Adams GG, Deleo FR, Musser JM. 2005. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc. Natl. Acad. Sci. U. S. A. 102:1679-1684.
25. Hollands A, Pence MA, Timmer AM, Osvath SR, Turnbull L, Whitchurch CB, Walker MJ, Nizet V. 2010. Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. J. Infect. Dis. 202:11-19.
26. Edwards RJ, Taylor GW, Ferguson M, Murray S, Rendell N, Wrigley A, Bai Z, Boyle J, Finney SJ, Jones A, Russell HH, Turner C, Cohen J,Faulkner L, Sriskandan S. 2005. Specific C-terminal cleavage and inactivationof interleukin-8 by invasive disease isolates of Streptococcus pyogenes. J. Infect. Dis. 192:783-790.
27. Rasmussen M, Eden A, Bjorck L. 2000. SclA, a novel collagen-like surface protein of Streptococcus pyogenes. Infect. Immun. 68:6370-6377.
28. Hauser AR, Schlievert PM. 1990. Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J. Bacteriol. 172:4536-4542.
29. Wessels MR, Goldberg JB, Moses AE, DiCesare TJ. 1994. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect. Immun. 62:433-441.
30. Perez N, Treviño J, Liu Z, Ho SC, Babitzke P, Sumby P. 2009. A genome-wide analysis of small regulatory RNAs in the human pathogen group A Streptococcus. PLoS One 4:e7668.
31. Dinkla K, Sastalla I, Godehardt AW, Janze N, Chhatwal GS, Rohde M, Medina E. 2007. Upregulation of capsule enables Streptococcus pyogenes to evade immune recognition by antigen-specific antibodies directed to the G-related alpha2-macroglobulin-binding protein GRAB located on the bacterial surface. Microbes Infect. 9:922-931.
32. Toppel AW, Rasmussen M, Rohde M, Medina E, Chhatwal GS. 2003. Contribution of protein G-related alpha2-macroglobulin-binding protein to bacterial virulence in a mouse skin model of group A streptococcal infection. J. Infect. Dis. 187:1694-1703.
33. Cywes C, Wessels MR. 2001. Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature 414:648-652.
34. Federle MJ, Scott JR. 2002. Identification of binding sites for the group A streptococcal global regulator CovR. Mol. Microbiol. 43:1161-1172.
35. Hammerstrom TG, Roh JH, Nikonowicz EP, Koehler TM. 2011. Bacillus anthracis virulence regulator AtxA: oligomeric state, function and CO(2) -signalling. Mol. Microbiol. 82:634-647.
36. Fouet A. 2010. AtxA, a Bacillus anthracis global virulence regulator. Res. Microbiol. 161:735-742.
37. Bourgogne A, Drysdale M, Hilsenbeck SG, Peterson SN, Koehler TM. 2003. Global effects of virulence gene regulators in a Bacillus anthracisstrain with both virulence plasmids. Infect. Immun. 71:2736-2743.
38. Bachem S, Stulke J. 1998. Regulation of the Bacillus subtilis GlcT antiterminator protein by components of the phosphotransferase system. J. Bacteriol. 180:5319-5326.
39. Tsvetanova B, Wilson AC, Bongiorni C, Chiang C, Hoch JA, Perego M. 2007. Opposing effects of histidine phosphorylation regulate the AtxA virulence transcription factor in Bacillus anthracis. Mol. Microbiol. 63: 644-655.
40. Godehardt AW, Hammerschmidt S, Frank R, Chhatwal GS. 2004. Binding of alpha2-macroglobulin to GRAB (protein G-related alpha2-macroglobulin-binding protein), an important virulence factor of group A streptococci, is mediated by two charged motifs in the DeltaA region. Biochem. J. 381:877-885.